GlassScriptPhysician profile
Alan M Garber
NPI 1225124787
$4,898,073.44
in general payments reported to CMS, 2019-2025
2 companies · $80K in 2025
The $80K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $988K · 2020: $959K · 2021: $955K · 2022: $608K · 2023: $654K · 2024: $654K · 2025: $80K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1.2M · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $148K · Travel and Lodging: $53K · Food and Beverage: $9,535 · Gift: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,178,342.40 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $147,750.00 |
| Travel and Lodging | $52,785.71 |
| Food and Beverage | $9,534.71 |
| Gift | $123.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $3,258,564.17 | 2019-2025 | |
| Exelixis INC. | $1,639,509.27 | 2019-2025 |
Research and ownership
$1,528,218.12 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Garber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.